Abstract: To provide a multiplexer that makes it possible to achieve a reduction in size and that minimizes the influence of the expansion of laser light on a multiplexing unit. A multiplexer is provided with a plurality of waveguides, multiplexing units that are provided at an intermediate location within the waveguides, and laser light sources, wherein: the first multiplexing unit is arranged at a position that is closest to the laser light sources; and the laser light sources that have an optical axis at a position that is separated from the transmission axis of the visible light that is introduced into the first multiplexing unit are arranged so that the optical axis is inclined with respect to the transmission axis and the outer periphery of laser light that expands at a predetermined expansion angle passes in front of the first multiplexing unit.

Abstract: The disclosure relates to a method of detecting circulating tumor cells (CTCs) in a subject, diagnosing cancer, and/or treating a subject in need thereof.

Abstract: To provide a multiplexer that makes it possible to achieve a reduction in size and that minimizes the influence of the expansion of laser light on a multiplexing unit. A multiplexer is provided with a plurality of waveguides, multiplexing units that are provided at an intermediate location within the waveguides, and laser light sources, wherein: the first multiplexing unit is arranged at a position that is closest to the laser light sources; and the laser light sources that have an optical axis at a position that is separated from the transmission axis of the visible light that is introduced into the first multiplexing unit are arranged so that the optical axis is inclined with respect to the transmission axis and the outer periphery of laser light that expands at a predetermined expansion angle passes in front of the first multiplexing unit.

Abstract: To provide a multiplexer that makes it possible to achieve a reduction in size and that minimizes the influence of the expansion of laser light on a multiplexing unit. A multiplexer is provided with a plurality of waveguides, multiplexing units that are provided at an intermediate location within the waveguides, and laser light sources, wherein: the first multiplexing unit is arranged at a position that is closest to the laser light sources; and the laser light sources that have an optical axis at a position that is separated from the transmission axis of the visible light that is introduced into the first multiplexing unit are arranged so that the optical axis is inclined with respect to the transmission axis and the outer periphery of laser light that expands at a predetermined expansion angle passes in front of the first multiplexing unit.

Abstract: To provide a multiplexer that makes it possible to achieve a reduction in size and that minimizes the influence of the expansion of laser light on a multiplexing unit. A multiplexer is provided with a plurality of waveguides, multiplexing units that are provided at an intermediate location within the waveguides, and laser light sources, wherein: the first multiplexing unit is arranged at a position that is closest to the laser light sources; and the laser light sources that have an optical axis at a position that is separated from the transmission axis of the visible light that is introduced into the first multiplexing unit are arranged so that the optical axis is inclined with respect to the transmission axis and the outer periphery of laser light that expands at a predetermined expansion angle passes in front of the first multiplexing unit.

Abstract: Provided is a method of measuring and comparing multimer FSP1 and monomer FSP1 by using an FSP1-specific antibody and the like.

Abstract: The present invention provides a method of detecting dermatophyte, which does not require a complicated operation such as an enzyme treatment and a heat treatment. The present invention provides a method of detecting dermatophyte, including a step of extracting a dermatophyte component from a sample with a treatment liquid containing a non-ionic surfactant or a zwitterionic surfactant, and a kit for diagnosing dermatophyte infection, containing a treatment liquid comprising the above surfactant, and an antibody specifically recognizing a dermatophyte component, which are housed in separate containers.

Abstract: The present invention provides a compound represented by the formula (I): or a salt thereof; and a method of quantitatively analyzing an amino group-containing target substance, including labeling a target substance in samples by using, as a labeling compound, two or more of such compounds having a mutually different mass due to isotope labeling, to confer a mass difference to the target substance between two or more samples, and the like.

Abstract: Implementation including a brain activity data acquisition unit configured to acquire data on brain activity of a human body; a generator configured to generate a stimulation signal based on predetermined stimulation parameters or stimulation parameters determined from the data acquired by the brain activity data acquisition unit, the stimulation signal being to be applied, for activity of a specific brain region to be activated in order to move a joint of the human body, to a nerve corresponding to the specific brain region; and an output unit configured to output the stimulation signal generated by the generator.

Abstract: The present invention provides a method of detecting dermatophyte, which does not require a complicated operation such as an enzyme treatment and a heat treatment. The present invention provides a method of detecting dermatophyte, including a step of extracting a dermatophyte component from a sample with a treatment liquid containing a non-ionic surfactant or a zwitterionic surfactant, and a kit for diagnosing dermatophyte infection, containing a treatment liquid comprising the above surfactant, and an antibody specifically recognizing a dermatophyte component, which are housed in separate containers.

Abstract: A structural fiber product usable as an adsorbent or the like is provided. A graft component for forming a graft chain is graft-polymerized onto a structural fiber object; the structural fiber object comprises a fiber assembly comprising at least a conjugated fiber, and an ethylene-vinyl alcohol-series copolymer exists on at least part of a surface of the fiber. The graft polymerization may be conducted, for example, by exposing a structural fiber object to radiation to generate an active species and immersing the structural fiber object in a liquid containing a graft component to bring the structural fiber object into contact with the graft component. According to the method, the graft component can be polymerized at a high degree of grafting, and a structural fiber product having an excellent adsorption characteristic is obtained.

Abstract: Disclosed are an oil state monitoring method and an oil state monitoring device which monitor the state of degradation of oil used in machinery or equipment. In monitoring the oil state by the oil state monitoring method and by the oil state monitoring device, oil used in machinery or equipment is filtered when the degradation state of the aforementioned oil is to be monitored. By means of filtration, the oil content is removed from the filter which captured contaminants that were present in oil prior to filtration. Light is projected onto the filter from which oil was removed. The projected light detects the color components of the transmitted light which penetrated the aforementioned filter.

Abstract: There are provided surface-modified fine fibers that preserve the inherent physical properties of a matrix polymer, the surface of which is efficiently modified, that can be easily produced, and that are formed by an electrospinning method from a spinning material that is a resin composition including a fluorine-containing highly branched polymer (a) and a thermoplastic resin (b); a method for producing the fiber; and a method for modifying the surface of fine fibers.

Abstract: A method of quantifying a target non-peptidic compound having an amino group contained in one or more biological samples, which comprises a step of producing a difference in the mass of the target non-peptidic compound between samples, by using a combination of two or more kinds of stable isotopes of a compound represented by the formula (I): wherein R1, R2 and R3 are the same or different and each is hydrogen, halogen or alkyl, or a salt thereof, as a labeling compound; and a kit and the like usable for such method.

Abstract: Disclosed are an oil state monitoring method and an oil state monitoring device which monitor the state of degradation of oil used in machinery or equipment. In monitoring the oil state by the oil state monitoring method and by the oil state monitoring device, oil used in machinery or equipment is filtered when the degradation state of the aforementioned oil is to be monitored. By means of filtration, the oil content is removed from the filter which captured contaminants that were present in oil prior to filtration. Light is projected onto the filter from which oil was removed. The projected light detects the color components of the transmitted light which penetrated the aforementioned filter.

Abstract: The present invention provides a protein analysis method using a combination of two or more kinds of stable isotopes of a compound represented by the formula (I): wherein R1, R2 and R3 are the same or different and each is hydrogen, halogen or alkyl, or a salt thereof, as a labeling compound to produce a difference in the mass of the same kind of protein contained in each sample.

Abstract: The present invention provides an agent for the prophylaxis or treatment of retinopathy or AMD containing PRDX 5 or PRDX 6, as well as an agent for the prophylaxis or treatment of retinopathy or AMD containing a polynucleotide encoding PRDX 5 or PRDX 6. The present invention also provides a method for the prophylaxis or treatment of retinopathy or AMD in a patient suffering from the disease, which includes administering to the patient an effective amount of PRDX 5 or PRDX 6, or administering to the patient an effective amount of a polynucleotide encoding PRDX 5 or PRDX 6.

Abstract: The invention provides easy handling and low cost-support equipment for measuring optical nerve-activity which is less stressful for subjects or doctors and the like. The support equipment, which provides light stimulation for subject eyes with its main body 10 fixed to the subject-head region and measures the subject optical nerve-activity, comprises a thin walled-main body 10 with a plurality of optical fibers 11 joined in the width direction; light emission regions 13a, 13b at least one of which is positioned in the main body aligned to the subject eye-position(s) and composed of a plurality of light leak parts 11c formed in peripheral surfaces of the optical fibers 11; and a connector 12a for connecting with a light emission device 12 providing light for each of the plurality of optical fibers.

Abstract: The present invention provides a stent and tubular organ treatment device that can flexibly deform according to a curved portion of a tubular organ, contracts less in the longitudinal direction during insertion, and is easy to handle. A stent (1) is formed into a tubular form by arranging five tubular unit bodies in an axial direction and connecting them by a connecting filament (F). Each tubular unit is formed into a closed loop by cutting a metal wire to a predetermined length, bending it in a zigzag manner in a peripheral direction, and securely connecting both ends thereof. A tubular unit body (W) having two bent portions projected in the axial direction is connected to and rockably retained by a tubular unit body (U1). Similarly, a tubular unit body (V) is rockably retained by the tubular unit body (W), whereby the entire stent can easily deform into a curved shape.

Abstract: A magnetizing device for superconductor and a superconducting synchronous machine are provided capable of constituting more compact and simple equipment that uses a superconductor as a magnet. The magnetizing device for superconductor includes a superconductor (131); a coolant chamber (142) for cooling the superconductor (131) down to or below a critical temperature at which the transition to a superconducting state occurs; coils (111, 111?) for generating a magnetic field equal to or higher than a critical magnetic field in which the intrusion of a magnetic flux into the superconductor (131) starts, around the superconductor (131) cooled down to or below the critical temperature at which the transition to the superconducting state occurs; and position modification means capable of arranging the superconductor (131) on a disk (120) and modifying the relative positional relationship with the coils (111, 111?).